NASDAQ:DXCM - Nasdaq - US2521311074 - Common Stock - Currency: USD
Taking everything into account, DXCM scores 6 out of 10 in our fundamental rating. DXCM was compared to 189 industry peers in the Health Care Equipment & Supplies industry. DXCM scores excellent on profitability, but there are some minor concerns on its financial health. DXCM is growing strongly while it is still valued neutral. This is a good combination! These ratings could make DXCM a good candidate for growth investing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.93% | ||
ROE | 23.61% | ||
ROIC | 14.54% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 16.54% | ||
PM (TTM) | 12.9% | ||
GM | 60.72% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.57 | ||
Debt/FCF | 4.35 | ||
Altman-Z | 6.02 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.5 | ||
Quick Ratio | 1.32 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 51.13 | ||
Fwd PE | 32.63 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 57.51 | ||
EV/EBITDA | 34.31 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:DXCM (5/23/2025, 2:27:00 PM)
84.365
-0.47 (-0.55%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 51.13 | ||
Fwd PE | 32.63 | ||
P/S | 7.98 | ||
P/FCF | 57.51 | ||
P/OCF | 34.31 | ||
P/B | 14.59 | ||
P/tB | 15.4 | ||
EV/EBITDA | 34.31 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.93% | ||
ROE | 23.61% | ||
ROCE | 18.47% | ||
ROIC | 14.54% | ||
ROICexc | 53.32% | ||
ROICexgc | 60.37% | ||
OM | 16.54% | ||
PM (TTM) | 12.9% | ||
GM | 60.72% | ||
FCFM | 13.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.57 | ||
Debt/FCF | 4.35 | ||
Debt/EBITDA | 1.42 | ||
Cap/Depr | 172.69% | ||
Cap/Sales | 9.38% | ||
Interest Coverage | 250 | ||
Cash Conversion | 105.79% | ||
Profit Quality | 107.47% | ||
Current Ratio | 1.5 | ||
Quick Ratio | 1.32 | ||
Altman-Z | 6.02 |